IL18

(redirected from iboctadekin)

IL18

A gene on chromosome 11q22.2-q22.3 that encodes IL-18, a proinflammatory cytokine that increases natural killer cell activity in spleen cells and stimulates interferon gamma production in T-helper type I cells.
References in periodicals archive ?
ABX MA1, Alfanative , ALLOVECTIN-7, AP 12009, Avastin, BAY 504798, Canvaxin, Carboplatin, Carmustine, Ceplene Maxamine, Cisplatin, CP 4055, Dacarbazine, Dexosome, Didemnin B, Ecromeximab, Elea Vaccine, EMD 273063, Enhanzyn, F 50040, Genasense, GMK, GV 1001, GVAX, Iboctadekin, ILX 651, INGN 241, INO 1001, Intron A, Kahalalide F, Karenitecin, KOS 953, Lenalidomide, Lomeguatrib, MDX-010, Melacine, Melphalan, MJV 101, M-VAX, NOVOVAC-M1, NY-ESO-1 ISCOMS, Oncophage, OncoVax, OncoVEXGM-CSF, Paclitaxel, PD 0325901, Peginterferon alfa-2b, Pivanex, Proleukin , ProMune, QS-21, SB 249553, SB 715992, Sorafenib, Talabostat, Tamoxifen, Temozolomide, Temozolomide, Uvidem, Vinblastine/Vinorelbine, Virulizin, Vitaxin, Zadaxin
AP 12009, BAY 504798, Bevacizumab, CANVAXIN, CP 4055, DISC-GMCSF, Endostatin, HSPPC 96, Iboctadekin, INO 1001, MEL-VAC, MTI 506, MTI SAM3, MX 128495, Oblimersen, ONCOFLU, OncoVax, OncoVEX GM-CSF, Peginterferon alfa-2b, PI 88, SGN 17/19, TC 101C, TG 1041, TRANSVAX, UVIDEM, VITAXIN MAb and many more.